Ironwood Pharmaceuticals | IRWD - Pre Tax Profit


Ironwood Pharmaceuticals reported $68.02M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 3.98M 22.34M Mar/2026
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Almirall EUR 30.32M 22M Dec/2025
Alnylam Pharmaceuticals USD 221.65M 60.52M Mar/2026
Amarin USD -852K 7.26M Dec/2025
Ardelyx USD -400K 467K Dec/2025
Astellas Pharma JPY 48.02B 85.93B Mar/2026
AstraZeneca USD 3.91B 1.28B Mar/2026
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Incyte USD 343.6M 46.34M Mar/2026
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Moderna USD -799M 612M Dec/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Pacira USD 571K 8.95M Dec/2025
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Sarepta Therapeutics USD 343.17M 750.85M Mar/2026
Takeda JPY -52.48B 186.34B Mar/2026
Ultragenyx Pharmaceutical USD -184M 56M Mar/2026
Vanda Pharmaceuticals USD -22.92M 16.68M Dec/2024